Plasminogen Activator Inhibitor-1-Positive Platelet-Derived Extracellular Vesicles Predicts MACE and the Proinflammatory SMC Phenotype

Richard G Jung, Anne-Claire Duchez, Trevor Simard, Shan Dhaliwal, Taylor Gillmore, Pietro Di Santo, Alisha Labinaz, F Daniel Ramirez, Adil Rasheed, Sabrina Robichaud, Mireille Ouimet, Spencer Short, Cole Clifford, Fengxia Xiao, Marie Lordkipanidzé, Dylan Burger, Suresh Gadde, Katey J Rayner, Benjamin Hibbert

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Patients with established coronary artery disease remain at elevated risk of major adverse cardiac events. The goal of this study was to evaluate the utility of plasminogen activator inhibitor-1-positive platelet-derived extracellular vesicles as a biomarker for major adverse cardiac events and to explore potential underlying mechanisms. Our study suggests these extracellular vesicles as a potential biomarker to identify and a therapeutic target to ameliorate neointimal formation of high-risk patients.

Original languageEnglish (US)
Pages (from-to)985-997
Number of pages13
JournalJACC: Basic to Translational Science
Volume7
Issue number10
DOIs
StatePublished - Oct 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Plasminogen Activator Inhibitor-1-Positive Platelet-Derived Extracellular Vesicles Predicts MACE and the Proinflammatory SMC Phenotype'. Together they form a unique fingerprint.

Cite this